Skip to main content

Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study

Publication ,  Conference
Simeone, JC; Tamayo, CAPTSG; Nordstrom, BL; Patel, MR; Yuan, Z; Sicignano, NM; Peacock, WF
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2016

Duke Scholars

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2016

Volume

25

Start / End Page

573 / 574

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Simeone, J. C., Tamayo, C. A. P. T. S. G., Nordstrom, B. L., Patel, M. R., Yuan, Z., Sicignano, N. M., & Peacock, W. F. (2016). Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 25, pp. 573–574). WILEY-BLACKWELL.
Simeone, Jason C., CAPT Sally G. Tamayo, Beth L. Nordstrom, Manesh R. Patel, Zhong Yuan, Nicholas M. Sicignano, and W Frank Peacock. “Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25:573–74. WILEY-BLACKWELL, 2016.
Simeone JC, Tamayo CAPTSG, Nordstrom BL, Patel MR, Yuan Z, Sicignano NM, et al. Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL; 2016. p. 573–4.
Simeone, Jason C., et al. “Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 25, WILEY-BLACKWELL, 2016, pp. 573–74.
Simeone JC, Tamayo CAPTSG, Nordstrom BL, Patel MR, Yuan Z, Sicignano NM, Peacock WF. Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL; 2016. p. 573–574.

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

EISSN

1099-1557

ISSN

1053-8569

Publication Date

August 1, 2016

Volume

25

Start / End Page

573 / 574

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences